scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Joshua Lambert | Q89126742 |
Moises A. Huamán | Q44830889 | ||
P2093 | author name string | Ye Li | |
Gaixin Du | |||
Alice Thornton | |||
Laura C Fanucchi | |||
Javier A Neyra | |||
Victor Ortiz-Soriano | |||
Katherine Donaldson | |||
Dan Cleland | |||
P2860 | cites work | Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury | Q21195041 |
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study | Q24634085 | ||
A new equation to estimate glomerular filtration rate | Q24651973 | ||
World incidence of AKI: a meta-analysis | Q30410807 | ||
Comorbidity measures for use with administrative data | Q32144770 | ||
Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. | Q33502046 | ||
New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service | Q34339285 | ||
Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y | Q34426508 | ||
Mortality from infective endocarditis: clinical predictors of outcome | Q35580053 | ||
Update on endocarditis-associated glomerulonephritis | Q35681967 | ||
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity | Q35903114 | ||
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017. | Q55262586 | ||
Subclinical AKI—an emerging syndrome with important consequences | Q61660694 | ||
Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System | Q64072994 | ||
Glomerulonephritis in bacterial endocarditis | Q71286790 | ||
Renal pathological findings in infective endocarditis | Q73173544 | ||
Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop | Q77950334 | ||
Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study | Q37598035 | ||
Acute kidney injury-epidemiology, outcomes and economics | Q38180360 | ||
Infective endocarditis: prevention, diagnosis, and management | Q38242652 | ||
Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence - North Carolina, 2010-2015. | Q38736362 | ||
Cost of Acute Kidney Injury in Hospitalized Patients | Q38969494 | ||
Patients with Infectious Endocarditis and Drug Dependence Have Worse Clinical Outcomes after Valvular Surgery | Q40072690 | ||
Tricuspid valve endocarditis | Q40135215 | ||
Trends in Infective Endocarditis in California and New York State, 1998-2013. | Q40227490 | ||
Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center | Q40314153 | ||
Morbidity and mortality of infective endocarditis in a hospital system in New York City serving a diverse urban population | Q40375839 | ||
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. | Q40405562 | ||
Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. | Q40938997 | ||
Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users | Q41196624 | ||
Subclinical AKI is still AKI | Q41890815 | ||
World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease | Q43439216 | ||
Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. | Q43469663 | ||
Glomerulonephritis with subacute bacterial endocarditis. Immunofluorescent studies | Q43818171 | ||
What endpoints should be used for clinical studies in acute kidney injury? | Q46054475 | ||
Health Care Costs Associated with AKI. | Q50099458 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P921 | main subject | acute kidney injury | Q424337 |
infective endocarditis | Q2450598 | ||
P577 | publication date | 2019-06-27 | |
P1433 | published in | Journal of Clinical Medicine | Q27724774 |
P1476 | title | Incidence and Cost of Acute Kidney Injury in Hospitalized Patients with Infective Endocarditis | |
P478 | volume | 8 |
Search more.